{"id":20906,"title":"MRI and Biomarkers in Prostate Cancer (Multi-IMPROD)","title_html":"MRI and Biomarkers in Prostate Cancer (Multi-IMPROD)","image":{"source":"https:\/\/s3.amazonaws.com\/pr-journal\/bdvka.png","placeholder":"https:\/\/s3.amazonaws.com\/pr-journal\/bdvka.png"},"doi":"dx.doi.org\/10.17504\/protocols.io.ynifvce","doi_status":2,"uri":"mri-and-biomarkers-in-prostate-cancer-multi-improd-ynifvce","type_id":1,"published_on":1551291037,"version_id":0,"created_on":1551289872,"categories":null,"creator":{"name":"Ivan Jambor","affiliation":null,"username":"ivan-jambor","link":"http:\/\/petiv.utu.fi\/multiimprod\/","image":{"source":"\/img\/avatars\/012.png","placeholder":"\/img\/avatars\/012.png"},"badges":[{"id":2,"image":{"source":"\/img\/badges\/bronze.svg","placeholder":"\/img\/badges\/bronze.svg"},"name":"Author"}],"research_interests":null},"journal":null,"journal_name":null,"journal_link":null,"public":1,"has_versions":0,"link":"http:\/\/petiv.utu.fi\/multiimprod\/","total_collections":0,"number_of_steps":0,"authors":[{"name":"Ivan Jambor","affiliation":"Janne Verho, Otto Ettala, Juha Knaapila, Pekka Taimen, Kari T. Syv\u00e4nen, Aida Kiviniemi, Esa K\u00e4hk\u00f6nen, Ileana Montoya Perez, Marjo Sepp\u00e4nen, Antti Rannikko, Outi Oksanen, Jarno Riikonen, Sanna Mari Vimpeli Tommi Kauko, Harri Merisaari, Markku Kallajoki, Tuomas Mirtti, Tarja Lamminen, Jani Saunavaara, Hannu J. Aronen, Peter J. Bostr\u00f6m","username":"ivan-jambor","link":null,"image":{"source":"\/img\/avatars\/012.png","placeholder":"\/img\/avatars\/012.png"},"badges":[],"research_interests":null}],"versions":[],"groups":[],"has_subprotocols":0,"is_subprotocol":0,"is_bookmarked":0,"forks_count":{"private":0,"public":0},"steps":[],"materials":[],"description":"<div class = \"text-blocks\"><div class = \"text-block\"><span>MULTI-IMPROD clinical trial (<\/span><a style = \"text-decoration:underline;color:blue;cursor:pointer;\"><span style = \":;\">ClinicalTrials.gov Identifier NCT02241122<\/span><\/a><span>) is a mutli-institutional validation trial of IMPROD trial (<\/span><a style = \"text-decoration:underline;color:blue;cursor:pointer;\"><span style = \":;\">NCT01864135<\/span><\/a><span>) using the same clinical trial set up, MRI acquisition and reporting system as IMPROD trial. Multi-IMPROD validated at 4 centers the use of high quality rapid 3 Tesla biparametric magnetic resonance imaging (bpMRI), T2-weighted imaging and three separate diffusion-weighted imaging acquisitions, combined with targeted biopsy (TB) for improving risk stratification of men with elevated prostate-specific antigen (PSA) before their first biopsy.<\/span><\/div><\/div>","changed_on":1551291037}